Notice of NINR Participation in NOT-EB-21-001 "Notice of Special Interest (NOSI): Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health"
Notice Number:
NOT-NR-23-003

Key Dates

Release Date:

November 29, 2022

Related Announcements

NOT-EB-21-001 - Notice of Special Interest (NOSI): Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health

Issued by

National Institute of Nursing Research (NINR)

Purpose

This Notice announces the participation of the National Institute of Nursing Research (NINR) in NOT-EB-21-001 Notice of Special Interest (NOSI): Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health, effective immediately.

NINR leads nursing research to solve pressing health challenges and inform practice and policy optimizing health and advancing health equity into the future. To achieve our mission, NINR has identified five complementary and synergistic research lenses that best leverage the strengths of nursing research and promote multilevel approaches, cross-disciplinary and -sectoral collaboration, and community engagement in research. For the purposes of this NOSI, NINR is interested in technology that will promote health equity, account for social determinants of health, and advance prevention and health promotion related to maternal morbidity and mortality.

NINR will accept responsive applications submitted to the following FOAs:

Activity Code FOA First Available Due Date
R41, R42 PA-22-178 - PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) January 05, 2023
R41, R42 PA-22-179 - PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) January 05, 2023
R43, R44 PA-22-176 - PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) January 05, 2023
R43, R44 PA-22-177 - PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) January 05, 2023
R41, R42, R43, R44 PA-20-272 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) Due dates may vary by awarding IC. See the awarding IC's web site. Applicants may also contact their respective awarding IC.















Inquiries

Please direct all inquiries to:

Kristopher Bough, PhD
National Institute of Nursing Research (NINR)
Telephone: 301-337-1372
Email: kristopher.bough@nih.gov